Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
Kristina B. Emdal, Anna-Kathrine Pedersen, Dorte B. Bekker‐Jensen, et al.
Science Signaling (2018) Vol. 11, Iss. 557
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

INKA , an integrative data analysis pipeline for phosphoproteomic inference of active kinases
Robin Beekhof, Carolien van Alphen, Alex A. Henneman, et al.
Molecular Systems Biology (2019) Vol. 15, Iss. 4
Open Access | Times Cited: 92
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
Qi Wu, Ai-Ling Tian, Bei Li, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002722-e002722
Open Access | Times Cited: 64
Phosphorylation Codes in IRS-1 and IRS-2 Are Associated with the Activation/Inhibition of Insulin Canonical Signaling Pathways
Anabel Martínez Báez, Guadalupe Ayala, Adolfo Pedroza-Saavedra, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 1, pp. 634-649
Open Access | Times Cited: 15
Targeting anaplastic lymphoma kinase in neuroblastoma
Ganesh Umapathy, Patricia Mendoza-García, Bengt Hallberg, et al.
Apmis (2019) Vol. 127, Iss. 5, pp. 288-302
Open Access | Times Cited: 71
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Marcus Borenäs, Ganesh Umapathy, Wei‐Yun Lai, et al.
The EMBO Journal (2021) Vol. 40, Iss. 3
Open Access | Times Cited: 51
Recent advances in kinase signaling network profiling by mass spectrometry
Giulia Franciosa, Marie Locard‐Paulet, Lars Juhl Jensen, et al.
Current Opinion in Chemical Biology (2023) Vol. 73, pp. 102260-102260
Open Access | Times Cited: 18
Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities
Yuxiang Zhang, David Remillard, Ugoma Onubogu, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 8, pp. 1160-1171
Open Access | Times Cited: 17
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
Kristina B. Emdal, Nicolàs Palacio-Escat, Caroline Wigerup, et al.
Cell Reports (2022) Vol. 40, Iss. 6, pp. 111177-111177
Open Access | Times Cited: 26
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression
Tzu‐Po Chuang, Wei‐Yun Lai, Jonatan L. Gabre, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 8
Open Access | Times Cited: 15
Cell-intrinsic insulin signaling defects in human iPS cell–derived hepatocytes in type 2 diabetes
Arijeet K. Gattu, Maria C. Tanzer, Tomer M. Yaron-Barir, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 8
Open Access
motifeR: An Integrated Web Software for Identification and Visualization of Protein Posttranslational Modification Motifs
Shisheng Wang, Yue Cai, Jingqiu Cheng, et al.
PROTEOMICS (2019) Vol. 19, Iss. 23
Closed Access | Times Cited: 32
Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer
Anna Magdalena Wulf, Marcela M. Moreno, Chloé A. Paka, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11718-11718
Open Access | Times Cited: 25
In vivo Profiling of the Alk Proximitome in the Developing Drosophila Brain
Ezgi Uçkun, Georg Wolfstetter, Vimala Anthonydhason, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 23, pp. 167282-167282
Open Access | Times Cited: 24
Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology
Esteban J. Rozen, Jason M. Shohet
Cancer and Metastasis Reviews (2021) Vol. 41, Iss. 1, pp. 33-52
Open Access | Times Cited: 24
IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway
Jikui Guan, Marcus Borenäs, Junfeng Xiong, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4252-4252
Open Access | Times Cited: 9
Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth
Wei‐Yun Lai, Tzu‐Po Chuang, Marcus Borenäs, et al.
Cell Death and Differentiation (2024)
Open Access | Times Cited: 3
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
Liselot Mus, Irina Lambertz, Shana Claeys, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 27
In Vitro Kinase-to-Phosphosite Database (iKiP-DB) Predicts Kinase Activity in Phosphoproteomic Datasets
Tommaso Mari, Kirstin Mösbauer, Emanuel Wyler, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 6, pp. 1575-1587
Open Access | Times Cited: 16
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN
Jonatan L. Gabre, Peter Merseburger, A. Claeys, et al.
NAR Cancer (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 2
From population to neuron: exploring common mediators for metabolic problems and mental illnesses
Yoichiro Takayanagi, Koko Ishizuka, Thomas Munk Laursen, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 3931-3942
Open Access | Times Cited: 17
Metabolic protein kinase signalling in neuroblastoma
William J. Smiles, Luca Catalano, Victoria E. Stefan, et al.
Molecular Metabolism (2023) Vol. 75, pp. 101771-101771
Open Access | Times Cited: 6
Proteomics for cancer drug design
Amanda Haymond, Justin B. Davis, Virginia Espina
Expert Review of Proteomics (2019) Vol. 16, Iss. 8, pp. 647-664
Open Access | Times Cited: 16
Proteomic investigation of Cbl and Cbl-b in neuroblastoma cell differentiation highlights roles for SHP-2 and CDK16
Anna-Kathrine Pedersen, Anamarija Pfeiffer, Gopal Karemore, et al.
iScience (2021) Vol. 24, Iss. 4, pp. 102321-102321
Open Access | Times Cited: 12
BioID-Screening Identifies PEAK1 and SHP2 as Components of the ALK Proximitome in Neuroblastoma Cells
Ezgi Uçkun, Joachim T. Siaw, Jikui Guan, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 19, pp. 167158-167158
Open Access | Times Cited: 11
SHP2 inhibition with TNO155 increases efficacy and overcomes resistance of ALK inhibitors in neuroblastoma
Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 12, pp. 2608-2622
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top